Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lethal giant larvae protein homolog 2 (LLGL2) is a highly conserved, non-enzymatic scaffolding protein that functions primarily in the regulation of apical-basal cell polarity, organization of cell junctions, and control of cell proliferation in epithelial tissues. LLGL2 is a core component of the Scribble polarity complex, along with Scribble (SCRIB) and Discs large (DLG), which antagonizes other polarity modules (such as Par and Crumbs complexes) to establish and maintain epithelial organization and tissue architecture. Structurally, LLGL2 contains a double β-propeller domain, and its association with the plasma membrane is regulated by phosphorylation via atypical protein kinase C (aPKC); this phosphorylation serves as a switch controlling its membrane localization and function[1][2][5]. Functionally, LLGL2 acts as a dynamic scaffold, regulating protein-protein interactions necessary for adherens and tight junction formation and maintenance, as well as maintaining epithelial barrier function and branching morphogenesis, such as in placental development[7]. As a tumor suppressor, the loss or dysfunction of LLGL2 is associated with disruption of cell polarity, increased ectopic proliferation, and promotion of tumorigenesis in various contexts[2][3][4]. Currently, LLGL2 is not a direct therapeutic target or known drug receptor, but its biological role as a tumor suppressor and regulator of epithelial integrity implicates it in diseases such as cancer and developmental defects when mutated or dysregulated[2][3][4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lethal giant larvae protein homolog 2 (LLGL2).